APT Medical Inc. (SHA:688617)
China
· Delayed Price · Currency is CNY 394.08
+2.08 (0.53%)
Jun 6, 2025, 2:45 PM CST
APT Medical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Market Capitalization | 38,317 | 36,094 | 25,854 | 20,463 | 18,668 | - | Upgrade
|
| Market Cap Growth | 31.79% | 39.61% | 26.35% | 9.62% | - | - | Upgrade
|
| Enterprise Value | 37,169 | 35,194 | 24,788 | 19,457 | 17,519 | - | Upgrade
|
| Last Close Price | 394.00 | 372.33 | 266.80 | 209.87 | 190.40 | - | Upgrade
|
| PE Ratio | 53.53 | 53.62 | 48.42 | 57.16 | 89.78 | - | Upgrade
|
| Forward PE | 42.98 | 41.69 | 41.48 | 50.33 | 65.88 | - | Upgrade
|
| PS Ratio | 17.62 | 17.47 | 15.67 | 16.83 | 22.53 | - | Upgrade
|
| PB Ratio | 14.00 | 14.13 | 13.18 | 11.43 | 10.42 | - | Upgrade
|
| P/TBV Ratio | 17.00 | 17.47 | 14.56 | 11.87 | 10.69 | - | Upgrade
|
| P/FCF Ratio | 183.30 | 387.51 | 53.09 | 91.25 | 1332.38 | - | Upgrade
|
| P/OCF Ratio | 48.17 | 48.55 | 37.52 | 55.69 | 102.92 | - | Upgrade
|
| EV/Sales Ratio | 17.09 | 17.04 | 15.02 | 16.00 | 21.14 | - | Upgrade
|
| EV/EBITDA Ratio | 43.12 | 42.28 | 42.73 | 47.96 | 86.10 | - | Upgrade
|
| EV/EBIT Ratio | 48.26 | 46.61 | 47.23 | 53.31 | 99.72 | - | Upgrade
|
| EV/FCF Ratio | 177.81 | 377.84 | 50.90 | 86.76 | 1250.43 | - | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.00 | 0.05 | 0.03 | 0.03 | 0.09 | Upgrade
|
| Debt / EBITDA Ratio | - | 0.01 | 0.15 | 0.13 | 0.22 | 0.31 | Upgrade
|
| Debt / FCF Ratio | - | 0.12 | 0.19 | 0.24 | 3.32 | 0.38 | Upgrade
|
| Asset Turnover | 0.76 | 0.74 | 0.69 | 0.57 | 0.64 | 0.83 | Upgrade
|
| Inventory Turnover | 0.06 | 1.57 | 1.46 | 1.18 | 1.27 | 0.99 | Upgrade
|
| Quick Ratio | 3.49 | 2.88 | 2.36 | 2.90 | 6.53 | 1.55 | Upgrade
|
| Current Ratio | 4.72 | 3.98 | 2.99 | 3.78 | 7.98 | 3.20 | Upgrade
|
| Return on Equity (ROE) | 29.58% | 29.14% | 27.82% | 18.99% | 17.39% | 26.18% | Upgrade
|
| Return on Assets (ROA) | 17.61% | 16.99% | 13.67% | 10.76% | 8.44% | 11.58% | Upgrade
|
| Return on Capital (ROIC) | 20.80% | 20.44% | 16.84% | 12.39% | 9.44% | 13.68% | Upgrade
|
| Return on Capital Employed (ROCE) | 29.20% | 29.30% | 26.40% | 20.10% | 9.70% | 22.20% | Upgrade
|
| Earnings Yield | 1.87% | 1.86% | 2.07% | 1.75% | 1.11% | - | Upgrade
|
| FCF Yield | 0.55% | 0.26% | 1.88% | 1.10% | 0.07% | - | Upgrade
|
| Dividend Yield | 0.45% | - | 0.52% | 0.54% | 0.36% | - | Upgrade
|
| Payout Ratio | 18.69% | 19.90% | 21.02% | 19.28% | 15.96% | 1.28% | Upgrade
|
| Buyback Yield / Dilution | 0.78% | 0.48% | 0.20% | -2.99% | -31.44% | 0.29% | Upgrade
|
| Total Shareholder Return | 1.23% | 0.48% | 0.72% | -2.45% | -31.08% | 0.29% | Upgrade
|
Updated Feb 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.